Physician profile
Jonathan Lopez
NPI 1790313062
$5,037.43
in general payments reported to CMS, 2019-2025
6 companies · $4,491 in 2025
The $4,491 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $546 · 2025: $4,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,775 · Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,774.75 |
| Food and Beverage | $1,262.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,599.48 | 2024-2025 | Ingevity Mri, Farapulse, Watchman Flx |
| Biotronik INC. | $1,792.54 | 2024-2025 | Renamic Neo, Rivacor 7 Dr-T, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $343.80 | 2024-2025 | Ensite, Cardiomems, Jot Dx |
| Cvrx, INC. | $125.02 | 2024 | Barostim Neo System |
| Medtronic, INC. | $101.89 | 2025 | Cobalt Dr Mri Surescan |
| Amgen INC. | $74.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.